Quality of life following radiofrequency ablation of dysplastic Barretts esophagus

N. J. Shaheen, A. F. Peery, R. H. Hawes, R. I. Rothstein, S. J. Spechler, J. A. Galanko, M. Campbell, C. Carr, B. Fowler, J. Walsh, A. A. Siddiqui, A. Infantolino, H. C. Wolfsen

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background and study aims: The impact of the diagnosis and treatment of dysplastic Barretts esophagus on quality of life (QoL) is poorly understood. This study assessed the influence of dysplastic Barretts esophagus on QoL and evaluated whether endoscopic treatment of dysplastic Barretts esophagus with radiofrequency ablation (RFA) improves QoL. Patients and methods: We analyzed changes in QoL in the AIM Dysplasia Trial, a multicenter study of patients with dysplastic Barretts esophagus who were randomly allocated to RFA therapy or a sham intervention. We developed a 10-item questionnaire to assess the influence of dysplastic Barretts esophagus on QoL. The questionnaire was completed by patients at baseline and 12 months. Results: 127 patients were randomized to RFA (n=84) or sham (n=43). At baseline, most patients reported worry about esophageal cancer (71% RFA, 85% sham) and esophagectomy (61% RFA, 68% sham). Patients also reported depression, impaired QoL, worry, stress, and dissatisfaction with the condition of their esophagus. Of those randomized, 117 patients completed the study to the 12-month end point. Compared with the sham group, patients treated with RFA had significantly less worry about esophageal cancer (P=0.003) and esophagectomy (P=0.009). They also had significantly reduced depression (P=0.02), general worry about the condition of their esophagus (P0.001), impact on daily QoL (P=0.009), stress (P=0.03), dissatisfaction with the condition of their esophagus (P0.001), and impact on work and family life (P=0.02). Conclusions: Inclusion in the treatment group of this randomized, sham-controlled trial of RFA was associated with improvement in disease-specific health-related quality of life. This improvement appears secondary to a perceived decrease in the risk of cancer.

Original languageEnglish (US)
Pages (from-to)790-799
Number of pages10
JournalEndoscopy
Volume42
Issue number10
DOIs
StatePublished - 2010

Fingerprint

Barrett Esophagus
Quality of Life
Esophagus
Esophagectomy
Esophageal Neoplasms
Depression
Therapeutics
Psychological Stress
Multicenter Studies
Randomized Controlled Trials

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Shaheen, N. J., Peery, A. F., Hawes, R. H., Rothstein, R. I., Spechler, S. J., Galanko, J. A., ... Wolfsen, H. C. (2010). Quality of life following radiofrequency ablation of dysplastic Barretts esophagus. Endoscopy, 42(10), 790-799. https://doi.org/10.1055/s-0030-1255780

Quality of life following radiofrequency ablation of dysplastic Barretts esophagus. / Shaheen, N. J.; Peery, A. F.; Hawes, R. H.; Rothstein, R. I.; Spechler, S. J.; Galanko, J. A.; Campbell, M.; Carr, C.; Fowler, B.; Walsh, J.; Siddiqui, A. A.; Infantolino, A.; Wolfsen, H. C.

In: Endoscopy, Vol. 42, No. 10, 2010, p. 790-799.

Research output: Contribution to journalArticle

Shaheen, NJ, Peery, AF, Hawes, RH, Rothstein, RI, Spechler, SJ, Galanko, JA, Campbell, M, Carr, C, Fowler, B, Walsh, J, Siddiqui, AA, Infantolino, A & Wolfsen, HC 2010, 'Quality of life following radiofrequency ablation of dysplastic Barretts esophagus', Endoscopy, vol. 42, no. 10, pp. 790-799. https://doi.org/10.1055/s-0030-1255780
Shaheen, N. J. ; Peery, A. F. ; Hawes, R. H. ; Rothstein, R. I. ; Spechler, S. J. ; Galanko, J. A. ; Campbell, M. ; Carr, C. ; Fowler, B. ; Walsh, J. ; Siddiqui, A. A. ; Infantolino, A. ; Wolfsen, H. C. / Quality of life following radiofrequency ablation of dysplastic Barretts esophagus. In: Endoscopy. 2010 ; Vol. 42, No. 10. pp. 790-799.
@article{62bed6b35d404edbb057012816663dcf,
title = "Quality of life following radiofrequency ablation of dysplastic Barretts esophagus",
abstract = "Background and study aims: The impact of the diagnosis and treatment of dysplastic Barretts esophagus on quality of life (QoL) is poorly understood. This study assessed the influence of dysplastic Barretts esophagus on QoL and evaluated whether endoscopic treatment of dysplastic Barretts esophagus with radiofrequency ablation (RFA) improves QoL. Patients and methods: We analyzed changes in QoL in the AIM Dysplasia Trial, a multicenter study of patients with dysplastic Barretts esophagus who were randomly allocated to RFA therapy or a sham intervention. We developed a 10-item questionnaire to assess the influence of dysplastic Barretts esophagus on QoL. The questionnaire was completed by patients at baseline and 12 months. Results: 127 patients were randomized to RFA (n=84) or sham (n=43). At baseline, most patients reported worry about esophageal cancer (71{\%} RFA, 85{\%} sham) and esophagectomy (61{\%} RFA, 68{\%} sham). Patients also reported depression, impaired QoL, worry, stress, and dissatisfaction with the condition of their esophagus. Of those randomized, 117 patients completed the study to the 12-month end point. Compared with the sham group, patients treated with RFA had significantly less worry about esophageal cancer (P=0.003) and esophagectomy (P=0.009). They also had significantly reduced depression (P=0.02), general worry about the condition of their esophagus (P0.001), impact on daily QoL (P=0.009), stress (P=0.03), dissatisfaction with the condition of their esophagus (P0.001), and impact on work and family life (P=0.02). Conclusions: Inclusion in the treatment group of this randomized, sham-controlled trial of RFA was associated with improvement in disease-specific health-related quality of life. This improvement appears secondary to a perceived decrease in the risk of cancer.",
author = "Shaheen, {N. J.} and Peery, {A. F.} and Hawes, {R. H.} and Rothstein, {R. I.} and Spechler, {S. J.} and Galanko, {J. A.} and M. Campbell and C. Carr and B. Fowler and J. Walsh and Siddiqui, {A. A.} and A. Infantolino and Wolfsen, {H. C.}",
year = "2010",
doi = "10.1055/s-0030-1255780",
language = "English (US)",
volume = "42",
pages = "790--799",
journal = "Endoscopy",
issn = "0013-726X",
publisher = "Georg Thieme Verlag",
number = "10",

}

TY - JOUR

T1 - Quality of life following radiofrequency ablation of dysplastic Barretts esophagus

AU - Shaheen, N. J.

AU - Peery, A. F.

AU - Hawes, R. H.

AU - Rothstein, R. I.

AU - Spechler, S. J.

AU - Galanko, J. A.

AU - Campbell, M.

AU - Carr, C.

AU - Fowler, B.

AU - Walsh, J.

AU - Siddiqui, A. A.

AU - Infantolino, A.

AU - Wolfsen, H. C.

PY - 2010

Y1 - 2010

N2 - Background and study aims: The impact of the diagnosis and treatment of dysplastic Barretts esophagus on quality of life (QoL) is poorly understood. This study assessed the influence of dysplastic Barretts esophagus on QoL and evaluated whether endoscopic treatment of dysplastic Barretts esophagus with radiofrequency ablation (RFA) improves QoL. Patients and methods: We analyzed changes in QoL in the AIM Dysplasia Trial, a multicenter study of patients with dysplastic Barretts esophagus who were randomly allocated to RFA therapy or a sham intervention. We developed a 10-item questionnaire to assess the influence of dysplastic Barretts esophagus on QoL. The questionnaire was completed by patients at baseline and 12 months. Results: 127 patients were randomized to RFA (n=84) or sham (n=43). At baseline, most patients reported worry about esophageal cancer (71% RFA, 85% sham) and esophagectomy (61% RFA, 68% sham). Patients also reported depression, impaired QoL, worry, stress, and dissatisfaction with the condition of their esophagus. Of those randomized, 117 patients completed the study to the 12-month end point. Compared with the sham group, patients treated with RFA had significantly less worry about esophageal cancer (P=0.003) and esophagectomy (P=0.009). They also had significantly reduced depression (P=0.02), general worry about the condition of their esophagus (P0.001), impact on daily QoL (P=0.009), stress (P=0.03), dissatisfaction with the condition of their esophagus (P0.001), and impact on work and family life (P=0.02). Conclusions: Inclusion in the treatment group of this randomized, sham-controlled trial of RFA was associated with improvement in disease-specific health-related quality of life. This improvement appears secondary to a perceived decrease in the risk of cancer.

AB - Background and study aims: The impact of the diagnosis and treatment of dysplastic Barretts esophagus on quality of life (QoL) is poorly understood. This study assessed the influence of dysplastic Barretts esophagus on QoL and evaluated whether endoscopic treatment of dysplastic Barretts esophagus with radiofrequency ablation (RFA) improves QoL. Patients and methods: We analyzed changes in QoL in the AIM Dysplasia Trial, a multicenter study of patients with dysplastic Barretts esophagus who were randomly allocated to RFA therapy or a sham intervention. We developed a 10-item questionnaire to assess the influence of dysplastic Barretts esophagus on QoL. The questionnaire was completed by patients at baseline and 12 months. Results: 127 patients were randomized to RFA (n=84) or sham (n=43). At baseline, most patients reported worry about esophageal cancer (71% RFA, 85% sham) and esophagectomy (61% RFA, 68% sham). Patients also reported depression, impaired QoL, worry, stress, and dissatisfaction with the condition of their esophagus. Of those randomized, 117 patients completed the study to the 12-month end point. Compared with the sham group, patients treated with RFA had significantly less worry about esophageal cancer (P=0.003) and esophagectomy (P=0.009). They also had significantly reduced depression (P=0.02), general worry about the condition of their esophagus (P0.001), impact on daily QoL (P=0.009), stress (P=0.03), dissatisfaction with the condition of their esophagus (P0.001), and impact on work and family life (P=0.02). Conclusions: Inclusion in the treatment group of this randomized, sham-controlled trial of RFA was associated with improvement in disease-specific health-related quality of life. This improvement appears secondary to a perceived decrease in the risk of cancer.

UR - http://www.scopus.com/inward/record.url?scp=77957303682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957303682&partnerID=8YFLogxK

U2 - 10.1055/s-0030-1255780

DO - 10.1055/s-0030-1255780

M3 - Article

VL - 42

SP - 790

EP - 799

JO - Endoscopy

JF - Endoscopy

SN - 0013-726X

IS - 10

ER -